35941689 31366731 31010002 33393506 26414293 36203359 33828464 30038936 24557878 33558455 34309017 22497875 30706387 23896725 22912830 22034026 25342621 27147738 31069169 23997910 29282655 32561864 32765219 32302639 22734691 22428978 32799685 2352711 - Search Results

Year	Number of Results
2008	2
2009	6
2010	12
2011	8
2012	15
2013	19
2014	18
2015	16
2016	9
2017	13
2018	10
2019	13
2020	17
2021	20
2022	10
2023	5

1

The tyrosine capsid mutations on retrograde adeno-associated virus accelerates gene transduction efficiency.

Nakahama R, Saito A, Nobe S, Togashi K, Suzuki IK, Uematsu A, Emoto K. Nakahama R, et al. Mol Brain. 2022 Aug 8;15(1):70. doi: 10.1186/s13041-022-00957-0. Mol Brain. 2022. PMID: 35941689 Free PMC article.

2

Gene manipulation in liver ductal organoids by optimized recombinant adeno-associated virus vectors.

Wei J, Ran G, Wang X, Jiang N, Liang J, Lin X, Ling C, Zhao B. Wei J, et al. J Biol Chem. 2019 Sep 20;294(38):14096-14104. doi: 10.1074/jbc.RA119.008616. Epub 2019 Jul 31. J Biol Chem. 2019. PMID: 31366731 Free PMC article.

3

Twenty-Five Years of Structural Parvovirology.

Mietzsch M, Pénzes JJ, Agbandje-McKenna M. Mietzsch M, et al. Viruses. 2019 Apr 20;11(4):362. doi: 10.3390/v11040362. Viruses. 2019. PMID: 31010002 Free PMC article. Review.

4

Overcoming innate immune barriers that impede AAV gene therapy vectors.

Muhuri M, Maeda Y, Ma H, Ram S, Fitzgerald KA, Tai PW, Gao G. Muhuri M, et al. J Clin Invest. 2021 Jan 4;131(1):e143780. doi: 10.1172/JCI143780. J Clin Invest. 2021. PMID: 33393506 Free PMC article. Review.

5

Perspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene Therapy.

Nance ME, Duan D. Nance ME, et al. Hum Gene Ther. 2015 Dec;26(12):786-800. doi: 10.1089/hum.2015.107. Epub 2015 Oct 15. Hum Gene Ther. 2015. PMID: 26414293 Free PMC article. Review.

6

AAV vectors: The Rubik's cube of human gene therapy.

Pupo A, Fernández A, Low SH, François A, Suárez-Amarán L, Samulski RJ. Pupo A, et al. Mol Ther. 2022 Dec 7;30(12):3515-3541. doi: 10.1016/j.ymthe.2022.09.015. Epub 2022 Oct 5. Mol Ther. 2022. PMID: 36203359 Free article. Review.

7

Dual-Viral Transduction Utilizing Highly Efficient Retrograde Lentivirus Improves Labeling of Long Propriospinal Neurons.

Brown BL, Zalla RM, Shepard CT, Howard RM, Kopechek JA, Magnuson DSK, Whittemore SR. Brown BL, et al. Front Neuroanat. 2021 Mar 22;15:635921. doi: 10.3389/fnana.2021.635921. eCollection 2021. Front Neuroanat. 2021. PMID: 33828464 Free PMC article.

8

A Novel Triple-Mutant AAV6 Capsid Induces Rapid and Potent Transgene Expression in the Muscle and Respiratory Tract of Mice.

van Lieshout LP, Domm JM, Rindler TN, Frost KL, Sorensen DL, Medina SJ, Booth SA, Bridges JP, Wootton SK. van Lieshout LP, et al. Mol Ther Methods Clin Dev. 2018 Apr 14;9:323-329. doi: 10.1016/j.omtm.2018.04.005. eCollection 2018 Jun 15. Mol Ther Methods Clin Dev. 2018. PMID: 30038936 Free PMC article.

9

Adeno-associated virus vectors and neurological gene therapy.

Ojala DS, Amara DP, Schaffer DV. Ojala DS, et al. Neuroscientist. 2015 Feb;21(1):84-98. doi: 10.1177/1073858414521870. Epub 2014 Feb 20. Neuroscientist. 2015. PMID: 24557878 Review.

10

Viral vector platforms within the gene therapy landscape.

Bulcha JT, Wang Y, Ma H, Tai PWL, Gao G. Bulcha JT, et al. Signal Transduct Target Ther. 2021 Feb 8;6(1):53. doi: 10.1038/s41392-021-00487-6. Signal Transduct Target Ther. 2021. PMID: 33558455 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

166 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Results by year